Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

AGM Result

22nd Jun 2007 10:45

For Immediate Release 22 June 2007 LiDCO Group Plc ('the Company') Result of Annual General Meeting

LiDCO, the UK based, AIM-quoted cardiovascular monitoring company is pleased to announce that all resolutions proposed at the Annual General Meeting, held on 21 June 2007 at 11:00am were duly passed.

- ENDS -

For more information please contact:

LiDCO Group Plc Tel: +44 (0)20 7749 1500

Terry O'Brien - Chief Executive

Buchanan Communications Tel: +44 (0)20 7466 5000

Tim Anderson, James StrongNotes for EditorsAbout LiDCO Group Plc

LiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier of minimally invasive, computer-based hemodynamic monitoring equipment and disposables used primarily for the management of critical care and cardiovascular risk hospital patients. Use of LiDCO's technology has been shown to significantly reduce the complications (particularly infections) and costs associated with major surgery. The technology was invented in the Department of Applied Physiology based at St Thomas' Hospital, London. For more information please see www.lidco.com.

The Company's manufacturing facility is in Hoxton, London and its current products are:

* LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume;

* LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner.

* LiDCOview - software product for use on a PC: designed to aide clinical audit, teaching and research activities.

* LiDCOlive - software product in development for the remote display of hemodynamic monitoring parameters derived through use of the LiDCOplus monitor.

Distribution Network:

The Company has now achieved registration of its products in 14 markets in Europe, the USA, Brazil, South Korea and Japan. It sells direct in the UK and USA, and elsewhere through a worldwide network of specialty critical care distributors.

LIDCO GROUP PLC

Related Shares:

LID.L
FTSE 100 Latest
Value8,845.40
Change35.66